Dominic P. D'AgostinoPhD · physiologist and pharmacologist, University of South Florida
Prefer ketone salts. Esters and 1,3-butanediol are the formulations that showed hepatic harm under chronic dosing.
What it rests onHis and Csilla Ari's rodent study (Pharmaceuticals, Sep 2025): four weeks and 83 days of oral dosing, with ketone salts maintaining normal liver structure while 1,3-butanediol and ketone ester produced macrovesicular steatosis, vascular congestion and raised TNF-alpha. Funded by the Office of Naval Research and a USF departmental grant. He declares his ketone patent portfolio and Ketone Technologies LLC, and separately, a company his wife founded sells ketone salts.
Source: pmc.ncbi.nlm.nih.gov ↗
